Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19

NCT04505774 is registered in ClinicalTrials.gov with Matthew Neal MD as lead sponsor.

NCT NCT04505774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04505774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults With COVID-19
Lead sponsor
Matthew Neal MD
Phase
Phase 4
Overall status
Completed
Start date
September 4, 2020
Completion date
January 26, 2024
Enrollment
3,591 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

covid19